Profile banner
Abhinav Kurada

Abhinav Kurada

Healthcare entrepreneur, biomedical researcher, and AI operations innovator

Philadelphia, Pennsylvania
Greater New York Area
Joined August 2025

Network

6.8K connections
📊
BCG Consultants
💰
Venture Capital Investors
💡
Startup Founders
🏥
CHLA Healthcare Leaders
🧬
Oncology Professionals
⚕️
Health Tech Innovators
🌐
...

Summary

Abhinav is a driven healthcare entrepreneur focused on leveraging AI and technology to improve patient care, particularly in oncology. His current venture, Oncare, aims to streamline clinical operations for cancer centers, demonstrating his commitment to addressing critical bottlenecks in healthcare delivery. tenoneten+1
His entrepreneurial spirit extends to his early career, where he co-founded NeuroTrak to develop innovative solutions for seizure monitoring, which earned him the VentureWell Venture Prize. He also co-founded MetroHacks in high school, showcasing an early passion for technology education and community building. nih+1
Academically, Abhinav combines a strong background in biomedical engineering from Columbia University, where he was an Egleston Scholar and engaged in computational neuroradiology research, with an MBA in Healthcare Management from The Wharton School. This interdisciplinary foundation positions him at the intersection of medical science and business strategy. columbia+2
Beyond his professional and academic pursuits, Abhinav has demonstrated a keen interest in intellectual competitions, notably as a two-time winner of the United States Geography Olympiad, highlighting a breadth of knowledge and competitive drive. iacompetitions+1

Work

Education

Projects

Hobbies

Has a strong interest in Biotech and Environmental Technology. medium

Participated in quizbowl competitions, including being a 2x winner of the United States Geography Olympiad. iacompetitions+1

Notes

LPLipsa Pandasaid they've seen
AKAbhinav Kurada
thrive in the ambiguity of a startup, driving growth and building lasting relationships with technical stakeholders.

Feb 22, 2026